The Social Security Fix

Autor: Robertson Ah

Publikováno v: Compensation Review. 15:63-70

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cde746ebda20e91d4f502ccb7f466273
https://doi.org/10.1177/088636878301500407

LESLIE JOHN JARVIS NYE

Autor: Robertson Ah

Publikováno v: Medical Journal of Australia. 2:623-624

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::994462422edd502a62864e196482e47b
https://doi.org/10.5694/j.1326-5377.1976.tb115287.x

Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, alpha, delta): A systematic review and meta-analysis of household contact studies.

Autor: Uthman OA; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Lyngse FP; Department of Economics & Center for Economic Behaviour and Inequality, University of Copenhagen, Copenhagen, Denmark., Anjorin S; Warwick Centre for Global Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom., Hauer B; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany., Hakki S; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez DA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Ge Y; School of Health Professions, University of Southern Mississippi, Hattiesburg, Mississippi, United States of America., Jonnerby J; School of Public Health, Imperial College London, London, United Kingdom., Julin CH; Division of Infection Control, Norwegian Institute of Public Health, Oslo, Norway., Lin G; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Lalvani A; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Loss J; Department of Epidemiology and Health Monitoring, Robert Koch-Institute, Berlin, Germany., Madon KJ; NIHR Health Protection Research Unit in Respiratory Infections, National Heart and Lung Institute, Imperial College London, London, United Kingdom., Martinez L; Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America., Næss LM; School of Public Health, Imperial College London, London, United Kingdom., Page KR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Prieto D; School of Industrial Engineering, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile., Robertson AH; School of Public Health, Imperial College London, London, United Kingdom., Shen Y; Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, United States of America., Wurm J; Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America., Buchholz U; Department for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.

Publikováno v: PloS one [PLoS One] 2024 Sep 06; Vol. 19 (9), pp. e0306740. Date of Electronic Publication: 2024 Sep 06 (Print Publication: 2024).

Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women.

Autor: Blix K; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Laake I; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Juvet L; Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway., Robertson AH; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Caspersen IH; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Mjaaland S; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Skodvin SN; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Magnus P; Centre for Fertility and Health, Norwegian Institute of Public Health, Oslo, Norway., Feiring B; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway., Trogstad L; Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.

Publikováno v: Science advances [Sci Adv] 2023 Sep 22; Vol. 9 (38), pp. eadg1391. Date of Electronic Publication: 2023 Sep 22.

Systematic review of the efficacy, effectiveness and safety of cell-based seasonal influenza vaccines for the prevention of laboratory-confirmed influenza in individuals ≥18 years of age.

Autor: Jordan K; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Murchu EO; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Health Policy & Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Comber L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Hawkshaw S; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Marshall L; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., O'Neill M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Teljeur C; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Harrington P; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland., Carnahan A; Public Health Agency of Sweden, Solna, Sweden.; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden., Pérez-Martín JJ; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; General Directorate of Public Health and Addictions, IMIB-Arrixaca, Murcia University, Murcia, Spain., Robertson AH; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway., Johansen K; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Jonge J; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Krause T; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Statens Serum Institut, Copenhagen, Denmark., Nicolay N; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Nohynek H; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Finnish Institute for Health and Welfare, Helsinki, Finland., Pavlopoulou I; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; School of Health Sciences, Faculty of Nursing, Pediatric Research Laboratory, National and Kapodistrian University of Athens, Athens, Greece.; National Advisory Committee on Immunisation, Hellenic Ministry of Health, Athens, Greece., Pebody R; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Institute of Epidemiology & Health, University College London, London, UK., Penttinen P; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; European Centre for Disease Prevention and Control, Stockholm, Sweden., Soler-Soneira M; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Vigilancia de Enfermedades Prevenibles por Vacunación, Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, Madrid, Spain., Wichmann O; European Centre for Disease Prevention and Control, EU/EEA National Immunisation Technical Advisory Group (NITAG) collaboration on newer and enhanced inactivated seasonal influenza vaccines, Stockholm, Sweden.; Immunization Unit, Robert Koch-Institute, Berlin, Germany., Ryan M; Health Technology Assessment, Health Information and Quality Authority (HIQA), Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity. Health Sciences, Dublin, Ireland.

Publikováno v: Reviews in medical virology [Rev Med Virol] 2023 May; Vol. 33 (3), pp. e2332. Date of Electronic Publication: 2022 Feb 08.